OS Therapies Incorporated
General ticker "OSTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $56.8M (TTM average)
OS Therapies Incorporated follows the US Stock Market performance with the rate: 6.0%.
Estimated limits based on current volatility of 5.8%: low 1.70$, high 1.91$
Factors to consider:
- Total employees count: 200000 as of 2024
- Top business risk factors: Operational and conduct risks, Operating losses, Capital raising, Going concern doubt, Construction delays
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.13$, 3.23$]
- 2026-12-31 to 2027-12-31 estimated range: [1.03$, 2.97$]
Short-term OSTX quotes
Long-term OSTX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $4.34MM | $6.81MM | $28.71MM |
| Operating Income | $-4.34MM | $-6.81MM | $-28.71MM |
| Non-Operating Income | $-3.45MM | $-2.10MM | $-0.05MM |
| Interest Expense | $3.45MM | $2.05MM | $0.00MM |
| R&D Expense | $3.22MM | $2.84MM | $16.36MM |
| Income(Loss) | $-7.79MM | $-8.91MM | $-28.75MM |
| Net Income(Loss)* | $-7.79MM | $-8.91MM | $-28.75MM |
| Stockholders Equity | $-24.02MM | $-3.27MM | $-6.10MM |
| Assets | $0.80MM | $5.54MM | $6.84MM |
| Operating Cash Flow | $-3.01MM | $-7.28MM | $-14.24MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.47MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-0.47MM |
| Financing Cash Flow | $2.87MM | $12.78MM | $9.44MM |
| Earnings Per Share** | $-0.39 | $-0.43 | $-0.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.